Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03008382 · ClinicalTrials.gov registry record · Phase 4
Interstitial Cystitis: Examination of the Central Autonomic Network
A Phase 4 study of Myofascial Pelvic Pain and Interstitial Cystitis/Painful Bladder Syndrome, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
- 2
- Study locations
NCT03008382: Completed Phase 4 study of Myofascial Pelvic Pain and Interstitial Cystitis/Painful Bladder Syndrome, sponsored by Virginia Commonwealth University.
NCT03008382 is a Phase 4 study of Myofascial Pelvic Pain and Interstitial Cystitis/Painful Bladder Syndrome that has completed, run by Virginia Commonwealth University. The registered enrollment target is 72 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03008382, a Phase 4 study of Myofascial Pelvic Pain and Interstitial Cystitis/Painful Bladder Syndrome, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
- 2
- Study locations
Study Summary
This proposal aims to move the science of chronic pelvic pain (CPP) from simple associations towards an investigation of cause and effect relationships. The investigators will determine whether the striking changes in autonomic nervous system responsiveness (ANS-R) contribute meaningfully to the pathogenesis of CPP.
Primary Outcome
The total GUPI score is calculated from the sum of the 3 scores from the subscales. There is no uniformity in the ranges of scores for the individual questions. The 3 subscales are: pain, urinary, and quality of life. The total score range can go from 0-45. The higher the score indicates more female urinary symptoms. Scores were calculated for each participant at weeks 4 (baseline), 12 (post-first intervention) and 24 (post-second intervention) of their participation in the study.
Conditions Studied
Interventions
- DRUG Placebo Oral Tablet
- DRUG Metoprolol Tartrate Oral Tablet
- OTHER No intervention- observational sub-study
Study Locations (2)
Illinois
- NorthShore University HealthSystem - Evanston
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2022-03-16 |
| Phase | Phase 4 |
What the finished NCT03008382 record still lists
NCT03008382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Myofascial Pelvic Pain appearing as the primary indexed condition, and to 3 interventions - of which Placebo Oral Tablet is the first listed.
NCT03008382 reports a single indexed study location in Illinois, Virginia.
Frequently Asked Questions
What is clinical trial NCT03008382 about?
NCT03008382 is a clinical study titled "Interstitial Cystitis: Examination of the Central Autonomic Network". This proposal aims to move the science of chronic pelvic pain (CPP) from simple associations towards an investigation of cause and effect relationships. The investigators will determine whether the striking changes in autonomic nervous system responsiveness (ANS-R) contribute meaningfully to the pat...
What is the current status of trial NCT03008382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2017-03-01. Estimated completion is 2022-03-16.
What conditions does trial NCT03008382 study?
This clinical trial studies the following conditions: Myofascial Pelvic Pain, Interstitial Cystitis/Painful Bladder Syndrome.
What interventions are being tested in trial NCT03008382?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Metoprolol Tartrate Oral Tablet (DRUG), No intervention- observational sub-study (OTHER).
Who is sponsoring clinical trial NCT03008382?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03008382 being conducted?
This trial has 2 study locations across Illinois, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myofascial Pelvic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03008382's enrollment target sits among peer trials
72 1035th of 2000 higher than 961 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI